Get the Stockscreener App
36.28
3.87%
-1.46
After Hours:
36.33
0.05
+0.14%
Bruker Corp stock is traded at $36.28, with a volume of 3.46M.
It is down -3.87% in the last 24 hours and down -22.71% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$37.74
Open:
$37.11
24h Volume:
3.46M
Relative Volume:
1.69
Market Cap:
$6.06B
Revenue:
$3.24B
Net Income/Loss:
$304.90M
P/E Ratio:
17.44
EPS:
2.08
Net Cash Flow:
$156.70M
1W Performance:
-4.70%
1M Performance:
-22.71%
6M Performance:
-40.02%
1Y Performance:
-56.26%
1-Day Range:
$36.16
$37.61
1-Week Range:
$36.16
$40.37
52-Week Range:
$34.10
$83.31
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
36.28 | 6.06B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
NMR Spectroscopy Market to Hit USD 2.08 Billion by 2032, Fueled by Pharmaceutical R&D and Rising Demand for Molecular Structure Analysis | SNS Insider - GlobeNewswire Inc.
Bruker Corporation (BRKR): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025 - Insider Monkey
A Glimpse Into The Expert Outlook On Bruker Through 6 Analysts - Nasdaq
Bruker to invest in German company RECIPE - Yahoo Finance
Groundbreaking 2-Gram Microscope Revolutionizes Neural Circuit Imaging with 300-Micron Deep Brain Access - Stock Titan
BRUKER CORP : Results of Operations and Financial Condition, Regulation FD Disclosure (form 8-K) - marketscreener.com
Bruker (BRKR) Acquires Majority Stake in RECIPE Chemicals + Instruments | BRKR Stock News - GuruFocus
Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring – Company AnnouncementFT.com - Financial Times
Bruker Stock May Benefit Following Its Investment in Ridom GmbH - Yahoo Finance
Bruker (BRKR) Projects Revenue Growth Amid Mixed Segment Performance | BRKR Stock News - GuruFocus
Form DEF 14A BRUKER CORP For: May 29 - StreetInsider
Why Is Life Science Focused Bruker Stock Trading Higher On Friday?Bruker (NASDAQ:BRKR) - Benzinga
Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain? - Yahoo Finance
Bruker Crushes Q1 Revenue Estimates: Double-Digit Growth Signals Strong Performance - Stock Titan
Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing - Yahoo Finance
Bruker Launches FoodScreener Module for Comprehensive NMR-based Profiling of Honey - Global Food Industry News
Is Now An Opportune Moment To Examine Bruker Corporation (NASDAQ:BRKR)? - Yahoo Finance
Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up - Nasdaq
Bruker unveils world’s first 1.3 GHz NMR spectrometer - Investing.com
Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System - Financial Times
Revolutionary Multi-Nuclear NMR Technology Transforms Pharma and Battery Research - Stock Titan
Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain? - MSN
Bruker installs novel MRI polarizer at UCSF for cancer research - Investing.com
Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR – Company AnnouncementFT.com - Financial Times
Game-Changing MRI Breakthrough: New Technology Delivers 10,000x Better Imaging for Cancer Research - Stock Titan
Bruker stock hits 52-week low at $42.68 amid market challenges By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $42.68 amid market challenges - Investing.com
Is Bruker Corporation (BRKR) an Oversold Value Stock to Buy According to Hedge Funds? - Insider Monkey
Bruker : Introduces eWARP, a Pioneering New EBSD Detector for Advanced Materials Characterization in Scanning Electron Microscopes - MarketScreener
Bruker stock hits 52-week low at $44 amid market challenges By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $44 amid market challenges - Investing.com
Victory Capital Management Inc. Decreases Stock Holdings in Bruker Co. (NASDAQ:BRKR)Insurance News - InsuranceNewsNet
Bruker Corporation (BRKR): Among Michael Burry’s Top Holdings - Insider Monkey
Based On Its ROE, Is Bruker Corporation (NASDAQ:BRKR) A High Quality Stock? - Yahoo Finance
Michael Burry’s Top Holdings Were Gaining While NVDA Was Crashing - Insider Monkey
Bruker Co. (NASDAQ:BRKR) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
FY2027 Earnings Estimate for Bruker Issued By Zacks Research - Defense World
BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail - Yahoo Finance
Bruker Co. (NASDAQ:BRKR) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Bruker at Leerink Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa
Bruker at Leerink Conference: Navigating Challenges and Opportunities - Investing.com
Bruker at Barclays Healthcare Conference: Navigating Headwinds and Tailwinds By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $45.13 amid market challenges - Investing.com Australia
Bruker Corp’s chief accounting officer buys $23,697 in stock - Investing.com India
Bruker at Barclays Healthcare Conference: Navigating Headwinds and Tailwinds - Investing.com
US Bancorp DE Has $694,000 Stock Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Proficio Capital Partners LLC Invests $608,000 in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker motion backfires in US patent dispute with 10x Genomics, Harvard - MLex
Zacks Research Predicts Bruker’s Q4 Earnings (NASDAQ:BRKR) - Defense World
Bruker Corp. to Host Earnings Call - ACCESS Newswire
Bruker at TD Cowen Conference: Strategic Growth in Healthcare - Investing.com
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bruker Corp Stock (BRKR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):